Provided by Tiger Fintech (Singapore) Pte. Ltd.

Klotho Neurosciences, Inc.

0.7201
-0.4099-36.27%
Post-market: 0.77750.0574+7.97%19:59 EDT
Volume:8.34M
Turnover:7.26M
Market Cap:23.40M
PE:-2.08
High:1.09
Open:1.09
Low:0.6808
Close:1.13
Loading ...

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

THOMSON REUTERS
·
24 Jun

Klotho Neuroscience Inc. Announces New Clinical Study on Klotho Protein's Role in Longevity and Neurodegenerative Disease Prevention in Partnership with Okinawa Research Center

Reuters
·
24 Jun

Klotho Neurosciences (Klto) Announces Mutual Termination of Share Exchange Agreement With Skybell Technologies (Skybell), to Continue Its Focus on Therapeutics and Longevity Programs

THOMSON REUTERS
·
18 Jun

Klotho Neurosciences Inc - No Liability Incurred by Klotho or Skybell From Termination

THOMSON REUTERS
·
18 Jun

Klotho Neurosciences Inc - Raises Over $11 Mln Through Warrant Exercises

THOMSON REUTERS
·
16 Jun

Klotho Neurosciences Inc - on June 9, Terminates Share Exchange Agreement With Skybell Technologies - SEC Filing

THOMSON REUTERS
·
14 Jun

Klotho Neurosciences Inc. Terminates Share Exchange Agreement with Skybell Technologies, Completes $500,000 Series B Preferred Stock Purchase

Reuters
·
14 Jun

Klotho Neuroscience Inc. Amends Warrant Pricing and Corrects Stock Purchase to 6.25 Million Shares for $500,000

Reuters
·
11 Jun

Why Is Klotho Neurosciences Stock (KLTO) Up 175% Today?

TIPRANKS
·
10 Jun

Klotho Neurosciences Shares Soar on Positive Anti-Aging Research

MT Newswires Live
·
09 Jun

US Stocks Mixed; Motorcar Parts of America Posts Upbeat Earnings

Benzinga
·
09 Jun

Klotho Neuroscience Inc. Conducted Special Stockholder Meeting

Reuters
·
03 Jun

Klotho Neurosciences Q1 EPS $(0.08)

Benzinga
·
15 May

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

GlobeNewswire
·
09 Jan